Semaglutide vs Tirzepatide: Research Comparison Guide 2025
“`html Semaglutide vs Tirzepatide: Research Comparison Guide 2025 Semaglutide and tirzepatide are two of the most studied incretin-based peptides in metabolic research, but they are not identical in mechanism or clinical performance. Semaglutide is a selective GLP-1 receptor agonist, while tirzepatide is a dual GIP/GLP-1 receptor agonist; in head-to-head studies, tirzepatide has generally produced greater […]